Skip to main content
Premium Trial:

Request an Annual Quote

Lloyd Old Dies

Premium

Cancer researcher Lloyd Old, who pioneered the field of cancer immunotherapy, died this week from prostate cancer, reports The New York Times. He was 78. He held a number of posts in his lifetime, including at Memorial Sloan-Kettering Cancer Center and at the Ludwig Institute for Cancer Research. Old studied the links between cancer and the immune system, and made it possible for others to develop cancer-fighting vaccines, the Times says. Old and his Sloan-Kettering colleague Edward Boyce were the first to discover cell-surface markers on cancer cells, leading to the conclusion that the immune system could be used to fight cancer. "It was considered unconventional — bordering on fringe — when Dr. Old began his work in the 1960s, but it is now a popular field and is listed on the Web site of the American Cancer Society as one of the standard options for cancer treatment, along with surgery, radiation and chemotherapy," the Times adds.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.